Skip to main navigation Skip to search Skip to main content

Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial

  • Stefan Siebert
  • , Arthur G. Pratt
  • , Deborah D. Stocken
  • , Miranda Morton
  • , Amy Cranston
  • , Michael Cole
  • , Sheelagh Frame
  • , Christopher D. Buckley
  • , Wan Fai Ng
  • , Andrew Filer
  • , Iain B. McInnes
  • , John D. Isaacs
  • University of Glasgow
  • Newcastle University
  • University of Leeds
  • Cyclacel Pharmaceuticals Inc
  • Birmingham Biomedical Research Centre
  • University of Oxford

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science